Foghorn Therapeutics Inc.
FHTX | NASDAQ
$4.25
+$0.10 (+2.41%)
Sep 22, 2026, 11:28 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 36.74M | 28.22M | 30.91M | 24.52M | 24.17M | 23.5M | 22.6M | 25.52M | 35.19M | 33.9M | 34.16M | 32.57M | 21.73M | 20.62M | 19.23M | 15.76M | 9.16M | 4.95M | 1.32M | 857K | 995K | 716K |
Cost of Revenue | 21.04M | 21.94M | 21.7M | 20.9M | 900K | n/a | n/a | 852K | 27.1M | 56.35M | 56.35M | 83.71M | 84.38M | 81.11M | 105.62M | 99.87M | 93.44M | 86.11M | 80.33M | 58.43M | 37.93M | 19.29M |
Gross Profit | 15.7M | 6.28M | 9.21M | 3.62M | 23.27M | 23.5M | 22.6M | 24.66M | 8.08M | -22.46M | -22.2M | -51.14M | -62.66M | -60.49M | -86.39M | -84.12M | -84.28M | -81.15M | -79.01M | -57.57M | -36.94M | -18.57M |
Operating Income | -68.48M | -80.77M | -82.11M | -86.52M | -91.87M | -97.4M | -102.68M | -104.14M | -97.37M | -102.78M | -107.91M | -114.33M | -125.51M | -122.65M | -117.14M | -113.33M | -111.34M | -105.41M | -100.73M | -93.43M | -85.66M | -77.94M |
Interest Income | 7.1M | 7.8M | 8.75M | 10.13M | 11.59M | 12.15M | 11.9M | 11.46M | 10.72M | 10.65M | 10.88M | 8.64M | 7.72M | 6.15M | 3.72M | 3.9M | 2.74M | 2.16M | 2.55M | 2.52M | 2.23M | 1.6M |
Pretax Income | -64.58M | -75.32M | -74.28M | -72.12M | -75.4M | -80.44M | -86.62M | -89.24M | -83.72M | -89.29M | -94.2M | -100.97M | -113.13M | -111.9M | -108.88M | -109.14M | -109.45M | -105.25M | -101.32M | -92.94M | -85.22M | -77.83M |
Net Income | -64.58M | -75.32M | -74.28M | -72.12M | -75.4M | -80.44M | -86.62M | -91.22M | -86.45M | -92.95M | -98.43M | -103.21M | -114.63M | -112.46M | -108.88M | -109.14M | -109.45M | -105.25M | -101.32M | -92.94M | -85.22M | -77.83M |
Selling & General & Admin | 26.38M | 26.89M | 27.55M | 27.11M | 27.43M | 27.89M | 28.36M | 29.03M | 30.37M | 31.44M | 32.37M | 33.21M | 32.87M | 32.17M | 30.75M | 29.22M | 27.06M | 24.25M | 21.73M | 19.96M | 16.7M | 13.72M |
Research & Development | 79.73M | 82.1M | 85.47M | 83.03M | 87.72M | 90.62M | 94.53M | 97.37M | 98.94M | 104.39M | 108.84M | 113.69M | 114.37M | 111.1M | 105.62M | 99.87M | 93.44M | 86.11M | 80.33M | 73.77M | 69.39M | 64.38M |
Other Expenses | -21.94M | -21.94M | -21.7M | -20M | n/a | 2.4M | 2.4M | 2.4M | -23.85M | -55.5M | -55.5M | -83.71M | -84.38M | -81.11M | -105.62M | -99.87M | -93.44M | -86.11M | -80.33M | -57.86M | -37.37M | -18.73M |
Operating Expenses | 84.17M | 87.05M | 91.31M | 90.13M | 115.14M | 120.91M | 125.29M | 128.8M | 105.45M | 80.33M | 85.71M | 63.2M | 62.85M | 62.16M | 30.75M | 29.22M | 27.06M | 24.25M | 21.73M | 35.86M | 48.72M | 59.36M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 426K | 925K | 1.42M | 1.91M | 1.8M | 1.5M | 1.21M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 105.21M | 108.99M | 113.02M | 111.03M | 116.04M | 120.91M | 125.29M | 129.65M | 132.55M | 136.68M | 142.06M | 146.9M | 147.24M | 143.27M | 136.37M | 129.09M | 120.5M | 110.36M | 102.05M | 94.29M | 86.65M | 78.65M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.99M | 2.72M | 3.67M | 4.23M | 2.24M | 1.5M | 560K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 70.63M | 69.54M | 62.98M | 63.03M | 62.98M | 62.85M | 62.6M | 62.6M | 51.58M | 42.43M | 42.28M | 42.03M | 41.83M | 41.81M | 41.8M | 41.67M | 41.52M | 41.37M | 36.97M | 36.97M | 36.85M | 36.82M |
Shares Outstanding (Diluted) | 70.63M | 69.54M | 62.98M | 63.03M | 62.98M | 62.85M | 62.6M | 62.6M | 51.58M | 42.43M | 42.28M | 42.03M | 41.83M | 41.81M | 41.8M | 41.67M | 41.52M | 41.37M | 36.97M | 36.97M | 36.85M | 36.82M |
EPS (Basic) | -0.99 | -1.17 | -1.18 | -1.14 | -1.20 | -1.37 | -1.66 | -1.92 | -1.95 | -2.20 | -2.34 | -2.59 | -2.81 | -2.77 | -2.67 | 2.77 | 2.62 | 2.65 | 2.66 | -1.96 | -1.76 | -1.84 |
EPS (Diluted) | -0.99 | -1.17 | -1.18 | -1.14 | -1.20 | -1.37 | -1.66 | -1.92 | -1.95 | -2.20 | -2.34 | -2.59 | -2.81 | -2.77 | -2.67 | 2.77 | 2.62 | 2.65 | 2.66 | -1.96 | -1.76 | -1.84 |
EBITDA | -62.49M | -72.53M | -70.9M | -68.78M | -72.17M | -78.58M | -84.76M | -87.28M | -81.63M | -85.86M | -90.75M | -97.52M | -109.7M | -108.53M | -105.56M | -105.43M | -105.22M | -100.56M | -96.82M | -88.78M | -81.97M | -75.41M |
EBIT | -64.58M | -75.32M | -74.28M | -72.12M | -75.4M | -81.69M | -87.88M | -90.49M | -84.98M | -89.29M | -94.2M | -100.97M | -113.13M | -111.9M | -108.88M | -108.71M | -108.53M | -103.83M | -100.04M | -91.76M | -84.35M | -77.26M |
Depreciation & Amortization | 2.09M | 2.79M | 3.38M | 3.34M | 3.22M | 3.11M | 3.12M | 3.21M | 3.34M | 3.43M | 3.45M | 3.45M | 3.43M | 3.37M | 3.32M | 3.28M | 3.3M | 3.27M | 3.23M | 2.98M | 2.37M | 1.84M |
Add to Watchlist
Select watchlists to add or remove FHTX